February 26–27, 2018
Agenda
February 26, 2018
8:30 a.m. | Welcome and Opening Remarks Catherine Spong, M.D. |
---|---|
8:35 a.m. | Review and Approval of Minutes from November's Meeting Catherine Spong, M.D. |
8:40 a.m. | Introduction of Task Force members |
8:45 a.m. | Summary and Discussion of Work Products from Meetings 1 and 2 |
8:45 a.m. | Review of Work Products and Recommendations from Meetings 1 and 2 Catherine Spong, M.D. |
9:15 a.m. | Discussion |
9:45 a.m. | BREAK |
10:00 a.m. | Public Comment Period |
10:45- a.m. | Panel: Lessons Learned from Pediatric Research Brief Overview of Presentations 10:45
Community involvement/groundswell
Mark Del Monte, J.D. 10:55
Best Pharmaceuticals for Children Act (BPCA) overview (PDF 182 KB)
Anne Zajicek, M.D., Pharm.D., FAAP 11:05
NIH and BPCA (PDF 263 KB)
Perdita Taylor-Zapata, M.D. 11:15
FDA and BPCA (PDF 261 KB)
Lynne Yao, M.D., FAAP 11:25
Industry perspective (PDF 1.9 MB)
Samuel Maldonado, M.D., M.P.H., FAAP |
11:35 a.m. | Discussion Moderator: Andrew Bremer, M.D., Ph.D. |
12:15 p.m. | LUNCH |
1:15 p.m. | Effective Communication Strategies with Health Care Providers and the Public on Information Relevant to Pregnant Women and Lactating Women |
1:15 p.m. | Communication Strategy Case Example: NICHD Safe to Sleep® Campaign (PDF 1 MB) Lorena Kaplan, M.P.H., CHES |
1:50 p.m. | Panel: Effective Communication Strategies with Health Care Providers on Information Relevant to Pregnant Women and Lactating Women Brief Overview of Presentations 1:50
Federal perspective
John Whyte, M.D., M.P.H. 2:00
Professional society perspective (PDF 510 KB)
Kerri Wade, M.P.A. 2:10
Industry perspective
Susan Kindig, M.D., J.D. 2:20
Health care provider perspective (PDF 225 KB)
Susan Givens, RNC-OB, M.P.H., LCCE |
2:30 p.m. | Discussion Moderator: Jeanna Piper, M.D. Additional panelists: Jeanne Sheffield, M.D., and Victoria Pemberton, RNC, M.S., CCRC |
3:15 p.m. | BREAK |
3:30 p.m. | Panel: Effective Communication Strategies with the Public on Information Relevant to Pregnant Women and Lactating Women Brief Overview of Presentations 3:30
Federal perspective (PDF 4 MB)
Jackie Rosenthal, M.P.A. 3:40
Professional society perspective (PDF 1 MB)
Bridgette Jones, M.D. 3:50
Professional organization perspective (PDF 1.3 MB)
Diane Spatz, Ph.D. 4:00
Industry perspective (PDF 338 KB)
Kristi Lengyel, M.B.A. 4:10
Patient perspectives (PDF 165 KB)
Susan Benjamin Feingold, Psy.D. |
4:20 p.m. | Discussion Moderator: Karin Bok, M.S., Ph.D. Additional panelists:Melissa Gorman, M.S.N., RN-BC, CCRN-K, and Lois Tschetter, Ed.D., RN, IBCLC, CNE |
4:50 p.m. | Recap of Meeting, Action Items, and Charge to Group Catherine Spong, M.D. |
5:00 p.m. | END OF DAY 1 |
February 27, 2018
8:00 a.m. | Recap of Day 1 and Outline and Goals for Day 2 Catherine Spong, M.D. |
---|---|
8:15 a.m. | A Plan to Identify and Address Gaps in Knowledge and Research Regarding Safe and Effective Therapies for Pregnant Women and Lactating Women, Including the Development of Such Therapies |
8:15 a.m. | Discussion: Options for a Plan or Plans Moderator: Shelli Avenevoli, Ph.D. |
10:00 a.m. | BREAK |
10:15 a.m. | Discussion Continues Moderator: Shelli Avenevoli, Ph.D. |
11:45 p.m. | LUNCH |
12:45 p.m. | Discussion of Key Points and Review of Recommendations |
12:45 p.m. | Discussion of Key Points for Effective Communication Strategies with Health Care Providers and the Public on Information Relevant to Pregnant Women and Lactating Women Catherine Spong, M.D. |
1:30 p.m. | Discussion of Key Points for a Plan to Identify and Address Gaps in Knowledge and Research Regarding Safe and Effective Therapies for Pregnant Women and Lactating Women, Including the Development of Such Therapies Catherine Spong, M.D. |
2:15 p.m. | Review of Recommendations from Meetings 1, 2, and 3 Catherine Spong, M.D. |
2:45 p.m. | Recap of Meeting, Action Items, and Charge to Group (PDF 168 KB) Catherine Spong, M.D. |
3:00 p.m. | END OF DAY 2, ADJOURN MEETING |
Return to Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) main page.